We have investigated the role of the host's CD1d-dependent innate antitumor immune response in a murine T-cell lymphoma model in vivo. We found that C57BL/6 wildtype (WT) mice inoculated with RMA/S cells transfected with murine CD1d1 died at the same rate as mice inoculated with vector-transfected cells. In contrast, natural killer T (NKT) cell-deficient CD1d or Ja18 knockout mice inoculated with CD1d-transfected RMA/S cells survived significantly longer than mice inoculated with vector-transfected RMA/S cells, implicating the involvement of invariant NKT (iNKT) cells in inhibiting antitumor activity in vivo. In contrast to the mutant mice, which produced more of the proinflammatory cytokines IFN-c and GM-CSF, WT mice produced significantly elevated amounts of IL-13. Antitumor activity in the knockout mice was not due to the development of CD1d-specific cytotoxic T lymphocytes or circulating antibodies. However, iNKT cell numbers were elevated in tumor-bearing mice. Thus, iNKT cells may be playing a negative role in the host's antitumor immune response against T-cell lymphomas in a CD1d-dependent manner. ' 2006 Wiley-Liss, Inc.Key words: T-cell lymphoma; RMA/S; invariant NKT cells; CD1d molecules; cytokines Despite apparent immunocompetence in the host, lymphomas can arise nonetheless, evading the body's attempts at tumor immunosurveillance. Following transformation, the host's innate immune response is essential in controlling the dissemination and growth of metastatic disease. Immunosurveillance against spontaneously occurring lymphomas is not well understood. Understanding the molecular mechanisms that regulate divergent arms of the immune response is a key to develop effective immunotherapies for many diseases, including cancer.1 Recent studies have suggested an immunosurveillance function for a unique subpopulation of T cells that play an important role in innate immunity called natural killer T (NKT) cells.2 NKT cells are defined as T cells expressing markers on the surface shared with NK cells, and that rapidly secrete both Th1 and Th2 cytokines upon T-cell receptor (TCR) ligation. 3,4 Rather than recognizing peptides presented by MHC class I or class II molecules, NKT cells recognize lipid antigens presented by the MHC class I-like CD1d molecule.5 NKT cells are key players in the regulation of antitumor immunity, particularly in experimental models of tumor immunotherapy, including IL-12 or a-galactosylceramide (a-GalCer) administration.6 In a mouse model in which tumors spontaneously regress after initial growth and then recur, the negative regulation of tumor immunosurveillance by IL-13, possibly produced by CD41 NKT cells, has been reported. 7,8 In a more recent study, the same group has shown that a reduction in pulmonary metastases in the CT26 nonregressor colon carcinoma model occurs following the elimination of CD4 1 NKT cells, further illustrating an inhibitory role for NKT cells in antitumor immunity. 9 To date, the role of invariant (Va14Ja18 1 ) NKT (iNKT) cells in the evasion of hematopoieti...